Table 2.
Echocardiographic data of 91 patients with mitral regurgitation (MR) submitted to transcatheter aortic valve implantation and followed up for 1 year
| Patients (n = 91) | Moderate/severe MR | Trace/mild MR | |||||
|---|---|---|---|---|---|---|---|
| Group 1 | Group 2 | p | Group 3 | Group 4 | p | ||
| (n = 8) | (n = 16) | (n = 62) | (n = 5) | ||||
| LVEF (%) | 62.5(19) | 47(35.5) | 59.5(14.75) | 0.358 | 64(16.50) | 67(43) | 0.848 |
| LVEDD (mm) | 50(10) | 53(8.5) | 49.5(9.75) | 0.326 | 50(10) | 45(24.5) | 0.905 |
| LVESD (mm) | 31.5(10.25) | 31.5(22.25) | 32(11.5) | 0.620 | 32(10.25) | 27.5(19.75) | 0.45 |
| LA (mm) | 45(9) | 50(6.25) | 46.5(9.5) | 0.539 | 43(8) | 48(8.5) | 0.135 |
| Maximum AoG (mm Hg) | 87(34.75) | 76.5(42) | 81(45.5) | 0.603 | 89(33.5) | 78(28) | 0.133 |
| Mean AoG (mm Hg) | 53(22.5) | 46.5(30.75) | 49(29.75) | 0.520 | 56(21) | 50(18.5) | 0.115 |
| AoVA (cm2) | 0.7(0.23) | 0.7(0.33) | 0.65(0.30) | 0.458 | 0.7(0.2) | 0.7(0.25) | 0.578 |
| SPAP (mm Hg) | 47.5(20.75) | 49(29) | 59.5(20.75) | 0.391 | 45(16) | 56(14) | 0.130 |
| Mitral stenosis (%) | 9 (9.9%) | 1 (12.5%) | 2 (12.5%) | 1.0 | 4 (9.3%) | 2 (40%) | 0.063 |
| Aortic regurgitation (%) | 1.0 | 1.0 | |||||
| Trace/mild | 83 (91%) | 7 (87.5%) | 15 (93.75%) | 56 (90.3%) | 5 (100%) | ||
| Moderate/severe | 8 (9%) | 1 (12.5%) | 1 (6.25%) | 6(9.7%) | 0 | ||
| Tricuspid regurgitation (%) | 0.829 | 0.269 | |||||
| Trace/mild | 76 (83.5%) | 5 (62.5%) | 12 (75%) | 55 (88.7%) | 4 (80%) | ||
| Moderate/severe | 12 (13.1%) | 3 (37.5%) | 4 (25%) | 4 (6.5%) | 1 (20%) | ||
| Not available | 3 (3.4%) | - | - | 3 (4.8%) | - | ||
Data expressed as median (interquartile interval) or frequency (%); LVEF: left ventricular ejection fraction; LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; LA: left atrium; AoG: aortic gradient; AoVA: aortic valve area; SPAP: systolic pulmonary artery pressure.